EPHX1 and ERCC2 polymorphisms are associated with cisplatin-induced nephrotoxicity and prognosis in Thai cancer patients.
Cisplatin is a widely used chemotherapeutic drug for various cancers. One of the common adverse effects of cisplatin is nephrotoxicity including acute kidney injury (AKI) and acute kidney disease (AKD). Single Nucleotide Polymorphisms (SNPs) can be used to identify cancer patients who are susceptibl...
Saved in:
| Main Authors: | Saad Ahmed, Jakris Eu-Ahsunthornwattana, Thanaporn Thamrongjirapat, Aruchalean Taweewongsounton, Yutthana Rittavee, Nintita Sripaiboonkit Thokanit, Montien Ngodngamthaweesuk, Pitichote Hiranyatheb, Thanyanan Reungwetwattana, Nuttapong Ngamphaiboon, Natini Jinawath |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0324699 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EPHX1 and ERCC2 polymorphisms are associated with cisplatin-induced nephrotoxicity and prognosis in Thai cancer patients
by: Saad Ahmed, et al.
Published: (2025-01-01) -
Generation and characterization of epoxide hydrolase 3 (EPHX3)-deficient mice.
by: Samantha L Hoopes, et al.
Published: (2017-01-01) -
A Comprehensive Analysis of Epoxide Hydrolase 2 (EPHX2) in Pan‐Cancer
by: Weiquan Hu, et al.
Published: (2025-03-01) -
Systematic review and meta-analysis of the relationship between EPHX1 polymorphisms and colorectal cancer risk.
by: Fei Liu, et al.
Published: (2012-01-01) -
Systematic Review and Meta-Analysis of the Relationship between EPHX1 Polymorphisms and the Risk of Head and Neck Cancer.
by: Hong Chen, et al.
Published: (2015-01-01)